Autoantibody recognition of distinctly modified forms of the U1-70-kd antigen is associated with different clinical disease manifestations

Eric L Greidinger, Livia Casciola-Rosen, Steven M. Morris, Robert W. Hoffman, Antony Rosen

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

Objective. To examine whether autoantibody recognition of modified forms of the U1-70-kd RNP antigen correlates with manifestations of rheumatic disease. Methods. Blinded to clinical disease manifestations, sera from 27 rheumatic disease patients with U1-70-kd antibodies were used to immunoblot control, apoptotic, and oxidatively modified HeLa cell lysates. Using densitometry, recognition of antigen fragments was quantitated. The presence or absence of 1) lupus skin disease and 2) Raynaud's phenomenon (RP) was determined for each patient by chart review. The ability of patient sera to recognize the different fragments was compared for patients with and without skin disease and with and without RP. Results. Patients with lupus skin disease had higher recognition of apoptotic U1-70 kd than did patients without skin disease (mean ± SD fragment recognition index [FRI] 1.35 ± 0.57 versus 0.95 ± 0.25; P < 0.024, by Student's t-test). Patients with RP had higher recognition of oxidatively modified U1-70 kd than did patients without RP (mean ± SD FRI 0.95 ± 0.80 versus 0.24 ± 0.22; P < 0.048). Conclusion. Recognition of apoptotically and oxidatively modified forms of the U1-70-kd autoantigen are associated with distinct clinical rheumatic disease manifestations. This finding provides in vivo evidence for the hypothesis that immune recognition of modified forms of self antigens may be relevant to the pathogenesis of systemic rheumatic diseases. Understanding the antigenic modifications to which patients react may help predict the expression of rheumatic syndromes.

Original languageEnglish
Pages (from-to)881-888
Number of pages8
JournalArthritis and Rheumatism
Volume43
Issue number4
DOIs
StatePublished - Sep 18 2000
Externally publishedYes

Fingerprint

Autoantibodies
Antigens
Raynaud Disease
Rheumatic Diseases
Skin Diseases
Autoantigens
Densitometry
Serum
HeLa Cells
Students
Antibodies

ASJC Scopus subject areas

  • Immunology
  • Rheumatology
  • Immunology and Allergy
  • Pharmacology (medical)

Cite this

Autoantibody recognition of distinctly modified forms of the U1-70-kd antigen is associated with different clinical disease manifestations. / Greidinger, Eric L; Casciola-Rosen, Livia; Morris, Steven M.; Hoffman, Robert W.; Rosen, Antony.

In: Arthritis and Rheumatism, Vol. 43, No. 4, 18.09.2000, p. 881-888.

Research output: Contribution to journalArticle

Greidinger, Eric L ; Casciola-Rosen, Livia ; Morris, Steven M. ; Hoffman, Robert W. ; Rosen, Antony. / Autoantibody recognition of distinctly modified forms of the U1-70-kd antigen is associated with different clinical disease manifestations. In: Arthritis and Rheumatism. 2000 ; Vol. 43, No. 4. pp. 881-888.
@article{5307e0844f5646baa0e889e448cdb909,
title = "Autoantibody recognition of distinctly modified forms of the U1-70-kd antigen is associated with different clinical disease manifestations",
abstract = "Objective. To examine whether autoantibody recognition of modified forms of the U1-70-kd RNP antigen correlates with manifestations of rheumatic disease. Methods. Blinded to clinical disease manifestations, sera from 27 rheumatic disease patients with U1-70-kd antibodies were used to immunoblot control, apoptotic, and oxidatively modified HeLa cell lysates. Using densitometry, recognition of antigen fragments was quantitated. The presence or absence of 1) lupus skin disease and 2) Raynaud's phenomenon (RP) was determined for each patient by chart review. The ability of patient sera to recognize the different fragments was compared for patients with and without skin disease and with and without RP. Results. Patients with lupus skin disease had higher recognition of apoptotic U1-70 kd than did patients without skin disease (mean ± SD fragment recognition index [FRI] 1.35 ± 0.57 versus 0.95 ± 0.25; P < 0.024, by Student's t-test). Patients with RP had higher recognition of oxidatively modified U1-70 kd than did patients without RP (mean ± SD FRI 0.95 ± 0.80 versus 0.24 ± 0.22; P < 0.048). Conclusion. Recognition of apoptotically and oxidatively modified forms of the U1-70-kd autoantigen are associated with distinct clinical rheumatic disease manifestations. This finding provides in vivo evidence for the hypothesis that immune recognition of modified forms of self antigens may be relevant to the pathogenesis of systemic rheumatic diseases. Understanding the antigenic modifications to which patients react may help predict the expression of rheumatic syndromes.",
author = "Greidinger, {Eric L} and Livia Casciola-Rosen and Morris, {Steven M.} and Hoffman, {Robert W.} and Antony Rosen",
year = "2000",
month = "9",
day = "18",
doi = "10.1002/1529-0131(200004)43:4<881::AID-ANR20>3.0.CO;2-G",
language = "English",
volume = "43",
pages = "881--888",
journal = "Arthritis and Rheumatology",
issn = "2326-5191",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

TY - JOUR

T1 - Autoantibody recognition of distinctly modified forms of the U1-70-kd antigen is associated with different clinical disease manifestations

AU - Greidinger, Eric L

AU - Casciola-Rosen, Livia

AU - Morris, Steven M.

AU - Hoffman, Robert W.

AU - Rosen, Antony

PY - 2000/9/18

Y1 - 2000/9/18

N2 - Objective. To examine whether autoantibody recognition of modified forms of the U1-70-kd RNP antigen correlates with manifestations of rheumatic disease. Methods. Blinded to clinical disease manifestations, sera from 27 rheumatic disease patients with U1-70-kd antibodies were used to immunoblot control, apoptotic, and oxidatively modified HeLa cell lysates. Using densitometry, recognition of antigen fragments was quantitated. The presence or absence of 1) lupus skin disease and 2) Raynaud's phenomenon (RP) was determined for each patient by chart review. The ability of patient sera to recognize the different fragments was compared for patients with and without skin disease and with and without RP. Results. Patients with lupus skin disease had higher recognition of apoptotic U1-70 kd than did patients without skin disease (mean ± SD fragment recognition index [FRI] 1.35 ± 0.57 versus 0.95 ± 0.25; P < 0.024, by Student's t-test). Patients with RP had higher recognition of oxidatively modified U1-70 kd than did patients without RP (mean ± SD FRI 0.95 ± 0.80 versus 0.24 ± 0.22; P < 0.048). Conclusion. Recognition of apoptotically and oxidatively modified forms of the U1-70-kd autoantigen are associated with distinct clinical rheumatic disease manifestations. This finding provides in vivo evidence for the hypothesis that immune recognition of modified forms of self antigens may be relevant to the pathogenesis of systemic rheumatic diseases. Understanding the antigenic modifications to which patients react may help predict the expression of rheumatic syndromes.

AB - Objective. To examine whether autoantibody recognition of modified forms of the U1-70-kd RNP antigen correlates with manifestations of rheumatic disease. Methods. Blinded to clinical disease manifestations, sera from 27 rheumatic disease patients with U1-70-kd antibodies were used to immunoblot control, apoptotic, and oxidatively modified HeLa cell lysates. Using densitometry, recognition of antigen fragments was quantitated. The presence or absence of 1) lupus skin disease and 2) Raynaud's phenomenon (RP) was determined for each patient by chart review. The ability of patient sera to recognize the different fragments was compared for patients with and without skin disease and with and without RP. Results. Patients with lupus skin disease had higher recognition of apoptotic U1-70 kd than did patients without skin disease (mean ± SD fragment recognition index [FRI] 1.35 ± 0.57 versus 0.95 ± 0.25; P < 0.024, by Student's t-test). Patients with RP had higher recognition of oxidatively modified U1-70 kd than did patients without RP (mean ± SD FRI 0.95 ± 0.80 versus 0.24 ± 0.22; P < 0.048). Conclusion. Recognition of apoptotically and oxidatively modified forms of the U1-70-kd autoantigen are associated with distinct clinical rheumatic disease manifestations. This finding provides in vivo evidence for the hypothesis that immune recognition of modified forms of self antigens may be relevant to the pathogenesis of systemic rheumatic diseases. Understanding the antigenic modifications to which patients react may help predict the expression of rheumatic syndromes.

UR - http://www.scopus.com/inward/record.url?scp=0033850903&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033850903&partnerID=8YFLogxK

U2 - 10.1002/1529-0131(200004)43:4<881::AID-ANR20>3.0.CO;2-G

DO - 10.1002/1529-0131(200004)43:4<881::AID-ANR20>3.0.CO;2-G

M3 - Article

C2 - 10765934

AN - SCOPUS:0033850903

VL - 43

SP - 881

EP - 888

JO - Arthritis and Rheumatology

JF - Arthritis and Rheumatology

SN - 2326-5191

IS - 4

ER -